State IL
Clinical Trials in Illinois
Recruiting clinical trials with at least one study location in Illinois. Data updated daily from ClinicalTrials.gov.
Top Conditions in Illinois
NCT06662786 Phase 3
Recruiting
A Study of Amivantamab and mFOLFOX6 or FOLFIRI Versus Cetuximab and mFOLFOX6 or ...
Condition
Colorectal Neoplasms
Enrollment
1,000 pts
Location
United States, Belgium, Brazil
Sponsor
Janssen Research & Development
NCT04683653 Phase 1, Phase 2
Recruiting
Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer
Condition
Endometrial Cancer
Enrollment
100 pts
Location
United States
Sponsor
University of Chicago
NCT06272045 N/A
Recruiting
Early Intervention to Promote Cardiovascular Health of Mothers and Children
Condition
Cardiovascular Health
Enrollment
6,618 pts
Location
United States
Sponsor
JHSPH Center for Clinical Tria
NCT02325674 N/A
Recruiting
MEASuRE: Metreleptin Effectiveness And Safety Registry
Condition
Generalised Lipodystrophy
Enrollment
100 pts
Location
United States, France, Germany
Sponsor
Amryt Pharma
NCT03547973 Phase 2
Recruiting
Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Canno...
Condition
Metastatic Urothelial Cancer
Enrollment
827 pts
Location
United States, France, Germany
Sponsor
Gilead Sciences
NCT05736666 N/A
Recruiting
Treadmill Perturbation Training for Fall Prevention After Total Knee Replacement
Condition
Knee Osteoarthritis
Enrollment
196 pts
Location
United States
Sponsor
University of Illinois at Chic
NCT05677451 Phase 3
Recruiting
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, ...
Condition
Chronic Spontaneous Urticaria
Enrollment
100 pts
Location
United States, Argentina, Canada
Sponsor
Novartis Pharmaceuticals
NCT01804686 Phase 3
Recruiting
A Long-term Extension Study of PCI-32765 (Ibrutinib)
Condition
Chronic Lymphocytic Leukemia
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT06665256 Phase 2
Recruiting
Phase 2 Study of Rapcabtagene Autoleucel in Myositis
Condition
Idiopathic Inflammatory Myopathies
Enrollment
123 pts
Location
United States, France, Germany
Sponsor
Novartis Pharmaceuticals
NCT06252753 N/A
Recruiting
Observational Study Protocol: LIVER-R
Condition
Hepatobiliary Cancers
Enrollment
4,490 pts
Location
United States, Australia, Austria
Sponsor
AstraZeneca
NCT06465810 N/A
Recruiting
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Condition
Transthyretin Amyloidosis
Enrollment
1,850 pts
Location
United States, Canada, China
Sponsor
AstraZeneca
NCT05526924 Phase 1
Recruiting
Dosing Study of Radiation Combined With Tislelizumab and Pamiparib in Patients W...
Condition
Head and Neck Cancer
Enrollment
30 pts
Location
United States
Sponsor
University of Chicago
NCT06422923 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral...
Condition
Epilepsy, Temporal Lobe
Enrollment
10 pts
Location
United States
Sponsor
Neurona Therapeutics
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilterit...
Condition
Acute Myeloid Leukemia
Enrollment
1,186 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Condition
High Grade Glioma
Enrollment
60 pts
Location
United States, Australia, Canada
Sponsor
Rigel Pharmaceuticals
NCT06145659 N/A
Recruiting
School-based Support for Pre-school Aged Children With Developmental Disabilitie...
Condition
Developmental Delay
Enrollment
320 pts
Location
United States
Sponsor
University of Illinois at Chic
NCT06794541 Phase 2
Recruiting
A Study to Evaluate the Safety and Tolerability of Eravacycline in Pediatric Pat...
Condition
Complicated Intra-abdominal Infections (cIAI)
Enrollment
35 pts
Location
United States
Sponsor
Tetraphase Pharmaceuticals, In
NCT05566769 N/A
Recruiting
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMO...
Condition
Neuromyelitis Optica
Enrollment
103 pts
Location
United States, France, Germany
Sponsor
Ad scientiam
NCT01429389 N/A
Recruiting
Specimen Collection from Pregnant Women At Increased Risk for Fetal Aneuploidy
Condition
Down Syndrome
Enrollment
2,000 pts
Location
United States, Canada
Sponsor
Sequenom, Inc.
NCT05805410 N/A
Recruiting
Neuromuscular Mechanisms of Specific Trunk Interventions in Children With CP
Condition
Child Behavior
Enrollment
44 pts
Location
United States
Sponsor
Shirley Ryan AbilityLab
NCT05104983 Phase 2
Recruiting
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study
Condition
Tuberous Sclerosis Complex
Enrollment
64 pts
Location
United States
Sponsor
Darcy Krueger
NCT06813820 N/A
Recruiting
RELIVE (Randomized Evaluation of Less Invasive Ventricular Enhancement) Trial
Condition
Left Ventricle Remodeling
Enrollment
135 pts
Location
United States
Sponsor
BioVentrix
NCT07089888 Phase 3
Recruiting
A Study of Dotinurad Versus Allopurinol in Tophaceous Gout
Condition
Tophaceous Gout
Enrollment
250 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT06719141 Phase 3
Recruiting
A Study to Investigate LP352 in Children and Adults With Developmental and Epile...
Condition
Developmental and Epileptic Encephalopathy
Enrollment
320 pts
Location
United States, Australia, Belgium
Sponsor
Longboard Pharmaceuticals
NCT05234125 N/A
Recruiting
Better Lifestyle Counseling for African American Women During Pregnancy
Condition
Overweight or Obesity
Enrollment
150 pts
Location
United States
Sponsor
University of Illinois at Chic